Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People's Republic of China and Mainland China. It operates through nine segments: Hematology Testing. Genetic Diseases and Rare Diseases, Infectious Diseases, Oncology, Neurology, Maternity-Related Diseases, Routine Testing, CROs and R&D Project, and Others. The company offers esoteric testing services for hematology, oncology, neuroscience and infectious diseases. It also engages in product development and technical services; reagent development and sales; car-t treatment; and E-commerce services. The company's research and development projects, including molecular biology detection, flow cytometry detection, cytogenetic detection, and pathological detection technologies. Kindstar Globalgene Technology, Inc. was founded in 2003 and is headquartered in Wuhan, the People's Republic of China.
Frequently asked questions
What sector does Kindstar Globalgene Tech Inc (9960) operate in?
Kindstar Globalgene Tech Inc belongs to the Healthcare sector and operates in the Diagnostics & Research industry.
What is Kindstar Globalgene Tech Inc (9960) current stock price?
As of the latest data, Kindstar Globalgene Tech Inc stock price is HK$0.90, with a previous close of HK$0.91. Kindstar Globalgene Tech Inc lost -HK$0.01 in the last trading session, representing a -0.55% loss.
What is Kindstar Globalgene Tech Inc (9960) current market capitalization?
Kindstar Globalgene Tech Inc market cap is approximately 894.54 million.
What is Kindstar Globalgene Tech Inc (9960) EBITDA?
Kindstar Globalgene Tech Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 6.67 million.
Does Kindstar Globalgene Tech Inc (9960) pay dividends?
Yes. Kindstar Globalgene Tech Inc pays annual dividends with an annualized yield of 10.56% and an estimated annual payout of HK$0.10 per share.
When is the next ex-dividend date for Kindstar Globalgene Tech Inc (9960)?
The next ex-dividend date is scheduled for June 09, 2027.
What is Kindstar Globalgene Tech Inc (9960) beta (volatility) score?
Kindstar Globalgene Tech Inc has a beta of 0.625, indicating lower volatility than the overall market.
